Protective role of Th17 cells in pulmonary infection
- 1 March 2016
- journal article
- review article
- Published by Elsevier BV in Vaccine
- Vol. 34 (13), 1504-1514
- https://doi.org/10.1016/j.vaccine.2016.02.021
Abstract
No abstract availableFunding Information
- United States-India Education Foundation
This publication has 100 references indexed in Scilit:
- TH17 deficiency in human diseaseJournal of Allergy and Clinical Immunology, 2012
- The many faces of Th17 cellsCurrent Opinion in Immunology, 2011
- Th17 Cells Mediate Clade-Specific, Serotype-Independent Mucosal ImmunityImmunity, 2011
- IL-17–Induced Pulmonary Pathogenesis during Respiratory Viral Infection and Exacerbation of Allergic DiseaseThe American Journal of Pathology, 2011
- TH17-Based Vaccine Design for Prevention of Streptococcus pneumoniae ColonizationCell Host & Microbe, 2011
- Diverse Targets of the Transcription Factor STAT3 Contribute to T Cell Pathogenicity and HomeostasisImmunity, 2010
- A novel IL-17-dependent mechanism of cross protection: Respiratory infection with mycoplasma protects against a secondary listeria infectionEuropean Journal of Immunology, 2009
- DC activated via dectin‐1 convert Treg into IL‐17 producersEuropean Journal of Immunology, 2008
- Molecular Antagonism and Plasticity of Regulatory and Inflammatory T Cell ProgramsImmunity, 2008
- The Biological Functions of T Helper 17 Cell Effector Cytokines in InflammationImmunity, 2008